Products for Research Use Only
RegisterLogin

ZN-c3

CAT: 0931-T9643-04Size: 10 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T9643-04Size:10 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
2376146-48-2
Target
Wee1
Related Pathways
Cell Cycle/Checkpoint
Purity
0.9998
Bioactivity
Azenosertib (ZN-c3) is a potent and selective Wee1 inhibitor with balanced potency, ADME, and pharmacokinetic properties.[1]
Smiles
C(C=C)N1N(C=2C(C1=O)=CN=C(NC3=CC=C(C=C3)N4CCN(C)CC4)N2)C=5N=C6C(=CC5)CC[C@@]6(CC)O
Molecular Formula
C29H34N8O2
Molecular Weight
526.63
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Chemical Information

Azenosertib

Azenosertib is an inhibitor of the tyrosine kinase Wee1 (Wee1-like protein kinase; Wee1A kinase; WEE1hu) with potential antineoplastic sensitizing activity. Although the exact mechanism of action by which this agent inhibits Wee1 has yet to be disclosed, upon administration of ZN-c3, this agent targets and inhibits Wee1. Inhibition of Wee1 promotes both premature mitosis and a prolonged mitotic arrest leading to cell death in susceptible tumor cells, such as p53-deficient or mutated human cancers that lack the G1 checkpoint, upon treatment with DNA-damaging chemotherapeutic agents. Unlike normal cells, most p53-deficient or mutated human cancers lack the G1 checkpoint as p53 is the key regulator of the G1 checkpoint and these cells rely on the G2 checkpoint for DNA repair to damaged cells. Annulment of the G2 checkpoint may therefore make p53-deficient tumor cells more vulnerable to antineoplastic agents and enhance their cytotoxic effect. Overexpression of Wee1 occurs in several cancer types and high expression of Wee1 is associated with poor outcomes. Wee1 phosphorylates Cdc2 in the Cdc2/cyclin B (CDK1/cyclin B) complex which blocks progression from G2 into mitosis; it negatively regulates the G2 checkpoint by disallowing entry into mitosis in response to DNA damage.

CAS Number2376146-48-2
PubChem CID139467635
IUPAC Name1-[(7R)-7-ethyl-7-hydroxy-5,6-dihydrocyclopenta[b]pyridin-2-yl]-6-[4-(4-methylpiperazin-1-yl)anilino]-2-prop-2-enylpyrazolo[3,4-d]pyrimidin-3-one
Molecular FormulaC29H34N8O2
Molecular Weight526.6
XLogP3.7
Topological Polar Surface Area101
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count9
Rotatable Bond Count7
Heavy Atom Count39
Formal Charge0
Complexity875
SMILES
CC[C@]1(CCC2=C1N=C(C=C2)N3C4=NC(=NC=C4C(=O)N3CC=C)NC5=CC=C(C=C5)N6CCN(CC6)C)O
InChI
InChI=1S/C29H34N8O2/c1-4-14-36-27(38)23-19-30-28(31-21-7-9-22(10-8-21)35-17-15-34(3)16-18-35)33-26(23)37(36)24-11-6-20-12-13-29(39,5-2)25(20)32-24/h4,6-11,19,39H,1,5,12-18H2,2-3H3,(H,30,31,33)/t29-/m1/s1
InChIKey
OXTSYWDBUVRXFF-GDLZYMKVSA-N
Chemical Structure
2D Structure
2D structure of Azenosertib
CAS: 2376146-48-2
CID: 139467635
Formula: C29H34N8O2
MW: 526.6
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight526.6
XLogP33.7
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count9
Rotatable Bond Count7
Exact Mass526.28047236
Monoisotopic Mass526.28047236
Topological Polar Surface Area101 Ų
Heavy Atom Count39
Formal Charge0
Complexity875
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes

Related Products

CatalogName
T202203-01ZN-c5
T87675-01ZN-A-1041
T73367-01Zn (BQTC)
T84974-01C3
T17013-01TCO-C3-PEG3-C3-amine
TRP-00490-01Cu/Zn Superoxide dismutase
T89942-01Zn (II) Mesoporphyrin IX
TYD-01758-01Zn (II) TMPyP tetrachloride
T212029-01Iodine-C3-O-C3-PEG-Boc
TN10240-01Platenomycin C3

Alternative Products

CatalogName
MBS3617334-01ZN-c3
C01421-1gAzenosertib (Zn-C3)
CK-bio-15538-01Zn-Metallothionein (Zn-MT) ELISA Kit
T1070320/KElectrode ZN
MBS5815517Zn(BQTC)
TRC-Z439750-25MGZn-Nicotianamine
C53MR1028Zn dust
HY-175260ZN-c5
HY-146287Zn (BQTC)
GTR19234544-01ZN-A-1041

Popular Products